PEPTIDE VON PAGE5

European patent · EP3380114 · In force

Register entry

Publication number
EP3380114
Application number
EP16805178
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 23, 2016
Published
Oct 3, 2018
Granted
Aug 3, 2022
Protection ends at the latest
Nov 22, 2036
Next annual fee due
Nov 30, 2026
IPC classes
A61K 39/00 (2006.01)
C07K 16/30 (2006.01)
Priority
GB 201520548 23.11.2015
PCT application
PCT/GB2016/053640 23.11.2016
PCT publication
WO2017/089758 01.06.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Jun 14, 2023

    Change

    Published in Swissreg on 14.06.2023

  5. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  6. Aug 3, 2022

    Granted

    Published in Swissreg on 03.08.2022

Parties

Holder

Adaptimmune Limited

101 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, GB

Immunocore Limited

92 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, GB

Inventor

SUN, Meidai

Abingdon Oxfordshire OX14 4RY, GB

POWLESLAND, Alex

Abingdon Oxfordshire OX14 4RY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.